RNA Metabolism: RNA Processing Notes
Overview of Eukaryotic RNA Processing
- RNA polymerase II coordinates the processing of precursor mRNA.
- Key steps:
- Capping
- Polyadenylation
- Transcription termination
- Ribozymes mediate RNA cleavage and splicing reactions.
- Structure and function of spliceosomes are critical for splicing.
- A single gene can produce multiple different mRNA transcripts.
RNA Transcripts and Splicing
- Co-transcriptional splicing: Splicing occurs before transcription is complete.
- Example: Human dystrophin gene has 79 exons, spans ~2,400 kb, takes ~16 hours to transcribe at ~40 nucleotides/sec.
- Introns: non-coding sequences that must be removed.
- Exons: coding sequences that remain.
- The 5′ end of mRNA is capped with 7-methylguanylate; protects RNA from exonuclease.
- The 3′ end is typically extended by a poly(A) tail.
Phosphorylation States of RNA Polymerase II
- Phosphorylation states of the C-terminal domain (CTD) dictate the activity of RNA polymerase II during transcription:
- Phosphorylation levels vary during stages:
- PIC assembly
- Promoter clearance and pausing for capping
- Productive elongation
- Different phosphorylation states recruit RNA processing factors.
RNA Capping
- The capping process involves:
- Hydrolysis of phosphate on the 5′ nucleotide (by RNA Triphosphatase).
- Addition of GMP (by RNA guanylyltransferase).
- Methylation of guanine to form the cap (by guanine methyltransferase).
Polyadenylation
- A poly(A) tail is added to the 3′ end of transcripts in two steps:
- Cleavage occurs downstream of the AAUAAA sequence (3’ UTR).
- A's (80-250) are added to form the poly(A) tail.
- The process requires:
- CPSF (cleavage/polyadenylation specificity factor)
- CstF (cleavage stimulatory factor)
- PAP (poly(A) polymerase)
Splicing Mechanisms
- Intron Splicing: Four classes:
- Group I and II: Self-splicing, do not require specific factors.
- Group I uses guanine nucleoside cofactor.
- Group II uses an A residue within the intron forming a lariat structure.
- Group III: Eukaryotic spliceosomal introns (largest class).
- Group IV: Some tRNAs that require ATP and an endonuclease.
- Ribozymes mediate many RNA processing reactions.
- The spliceosome consists of ~150 proteins and 5 snRNAs that carry out splicing.
Spliceosome Assembly and Function
- Spliceosome recognizes splice sites through short consensus sequences surrounding 5′ and 3′ splice sites.
- Major steps:
- U1 binds to the 5′ splice junction.
- U2 binds the intron branch point.
- U4/U6 and U5 snRNPs join to form the catalytic spliceosome.
- The excision of the intron occurs via two transesterification reactions, forming a lariat structure.
Regulatory Factors in Splicing
- Exonic splicing enhancers (ESEs) and SR proteins influence splicing decision.
- Splicing factors coordinate with the phosphorylated CTD to enhance processing specificity.
Alternative Splicing
- Alternative splicing allows a single gene to generate multiple mRNA variants, leading to diverse protein products.
- Regulated by activators and repressors; splicing machinery can recognize different splicing signals based on cellular context.
Pathophysiology Implications of Splicing
- Splicing defects can lead to diseases by affecting genetic diversity and causing mis-splicing.
- Example: IRE1α-XBP1s splicing pathway is involved in cancer signaling (UPR - Unfolded Protein Response).
Summary of Key Points
- All RNA is synthesized via template-dependent copying by RNA polymerase.
- Eukaryotic pre-mRNA undergoes extensive processing including capping, splicing, and polyadenylation.
- The spliceosome plays a critical role in recognizing, excising introns, and ligating exons. Alternative splicing allows for versatility in protein synthesis.
Review Questions
- Discuss the importance of the phosphorylation states of RNA polymerase II CTD in splicing and transcription.
- Compare the mechanisms of group I and group II introns.
- Describe the role of snRNPs in the splicing process and their structural importance in the spliceosome.